The Medicines and Healthcare products Regulatory Agency (MHRA) has given marketing authorisation for Mounjaro, a new therapy, to treat type 2 diabetes in adults. This authorization comes after positive results from clinical trials that showed Mounjaro effectively reduces blood sugar levels in patients. Mounjaro is a a once-weekly injecti… Read More